Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis

Registry- based cohort study of 347 patients with MS, identified neurological disability, age, and obesity as independent risk factors for severe forms of COVID-19, but no association was found between disease-modifying therapies exposure and COVID-19 severity.

JAMA Neurology